Pioglitazone (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pioglitazone" in French language version.

refsWebsite

Global rank French rank

3afssaps.fr

low place

3,181^st place

3ahajournals.org

3,608^th place

659^th place

2nejm.org

2,374^th place

298^th place

2prescrire.org

low place

2,283^rd place

2bmj.com

1,226^th place

347^th place

1qmul.ac.uk

1,735^th place

168^th place

1wiley.com

222^nd place

129^th place

1jci.org

low place

3,702^nd place

1tandfonline.com

507^th place

420^th place

1onlinejacc.org

low place

2,587^th place

1egora.fr

low place

9,648^th place

1has-sante.fr

9,562^nd place

535^th place

1jamanetwork.com

2,650^th place

689^th place

afssaps.fr

ahajournals.org

bmj.com

(en) Azoulay L, Yin H, Filion KB, Assayag J et al. « The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study » BMJ. 2012;344:e3645.
(en) Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L, « Pioglitazone use and risk of bladder cancer: population based cohort study » BMJ. 2016;352:i1541.

egora.fr

« LMC : des résultats spectaculaires avec la pioglitazone », sur www.egora.fr, 3 septembre 2015

has-sante.fr

« ACTOS (Pioglitazone) », sur Haute Autorité de Santé (consulté le 13 décembre 2022)

jamanetwork.com

jama.jamanetwork.com

(en) Lewis JD, Habel LA, Quesenberry CP et al. « Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes » JAMA. 2015;314:265-77.

jci.org

(en) Buchanan TA, Meehan WP, Jeng YY. et al. « Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect » J Clin Invest. 1995;96:354–60.

nejm.org

(en) DeFronzo RA, Tripathy D, Schwenke DC. et al. « Pioglitazone for diabetes prevention in impaired glucose tolerance » N Eng J Med. 2011;364:1104-15.
(en) Kernan WN, Viscoli CM, Furie KL et al. « Pioglitazone after ischemic stroke or transient ischemic attack » N Engl J Med. 2016;374:1321–31.

onlinejacc.org

{{}} Mani P, Uno K, St John J. et al. « Favorable impact on LDL particle size in response to treatment with pioglitazone is associated with less progression of coronary atherosclerosis in patients with type 2 diabetes » J Am Coll Cardiol. 2015;66:328–329

prescrire.org

Avis de la revue Prescrire[1].
« Diabète : encore des données impliquant la pioglitazone à l’origine de cancers de la vessie (Actos° et associé à la metformine dans Competact°) » [4], Prescrire 1^er décembre 2010.

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

tandfonline.com

(en) Khan S, Khan S, Imran M, Pillai KK, Akhtar M, Najmi AK, « Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus–targeting thrombogenesis », Expert Opin Ther Targets. 2013;17:627–39.

wiley.com

onlinelibrary.wiley.com

(en) Betteridge DJ, « Effects of pioglitazone on lipid and lipoprotein metabolism » Diabetes Obes Metab. 2007;9:640–7.

Pioglitazone (French Wikipedia)

afssaps.fr

ahajournals.org

stroke.ahajournals.org

atvb.ahajournals.org

circ.ahajournals.org

bmj.com

egora.fr

has-sante.fr

jamanetwork.com

jama.jamanetwork.com

jci.org

nejm.org

onlinejacc.org

prescrire.org

qmul.ac.uk

chem.qmul.ac.uk

tandfonline.com

wiley.com

onlinelibrary.wiley.com